Spleenex VH
NDC 44911-0294, Aralia Quinquefolia, Ginkgo Biloba, Pancreas Suis, Spleen (Suis), Stomach (Suis), Germanium Sesquioxide, Cobaltum Metallicum, Niccolum Metallicum, Zincum Metallicum, Alpha-Ketoglutaricum Acidum, Citricum Acidum, Fumaricum Acidum, Malic Acid, Pyruvic Acid, Succinicum Acidum, Naphthoquinone, Baryta Carbonica, Phosphoricum Acidum, Aconiticum Acidum, Cis, Magnesium Gluconicum Dihydricum, Nux Vomica, Phosphorus, liquid, from Energique, Inc..
- Product NDC
- 44911-0294
- Status
- Listed
- Labeler
- Energique, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0294 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMERICAN GINSENG3 [hp_X]/mL
- GINKGO6 [hp_X]/mL
- SUS SCROFA PANCREAS6 [hp_X]/mL
- SUS SCROFA SPLEEN6 [hp_X]/mL
- SUS SCROFA STOMACH6 [hp_X]/mL
- GERMANIUM SESQUIOXIDE8 [hp_X]/mL
- COBALT8 [hp_X]/mL
- NICKEL8 [hp_X]/mL
- ZINC8 [hp_X]/mL
- OXOGLURIC ACID8 [hp_X]/mL
- ANHYDROUS CITRIC ACID8 [hp_X]/mL
- FUMARIC ACID8 [hp_X]/mL
- MALIC ACID8 [hp_X]/mL
- PYRUVIC ACID8 [hp_X]/mL
- SUCCINIC ACID8 [hp_X]/mL
- NAPHTHOQUINE9 [hp_X]/mL
- BARIUM CARBONATE12 [hp_X]/mL
- PHOSPHORIC ACID12 [hp_X]/mL
- ACONITIC ACID, (Z)-12 [hp_X]/mL
- MAGNESIUM GLUCONATE12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED12 [hp_X]/mL
- PHOSPHORUS12 [hp_X]/mL
Pharmacologic classes
Acidifying Activity [MoA]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Decreased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Non-Standardized Plant Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44911-0294-1 | 44911029401 | 30 mL in 1 BOTTLE, DROPPER (44911-0294-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 44911-0294 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44911-0294 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44911-0294. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.